B2UZ25 AF NFT

Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibsknduiu574sfrvvyalb77hzybpqaug6vt7tt4dpvgzzmzzc4sy4/metadata.json
IPFS of structure file: 
bafybeifc53cbfwl3all5arik6y56zar56nqk47xfvbjfmr7kkwz7chdpla/AF-B2UZ25-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x28fdd3B14dbA8880a8e7963Eb017057f4385ECCC
First NFT owner address (bech32): 
genesis19r7a8v2dh2ygp288jcltq9c90apctmxv0se9lc
Current NFT ID #142497 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
142497
Accession (UniProt):
B2UZ25
Name::
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2UZ25 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2UZ25|GATC_CLOBA Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=gatC PE=3 SV=1 MSVTKKDVEYVAELARLSFNEDEKESLASDLNQILNYVEKLQELDTEKEDIIVNPYYIENKFREDEITPSIKLEEVLENAPKTLEEYVLVPTIIREQ